MedTrace Logo

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

NCT00774787 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2016-11-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if use of topical imiquimod cream after cryotherapy of actinic keratoses reduces the total number of lesions (those treated with cryotherapy and new ones) at follow-up.

Conditions

  • Actinic Keratoses

Interventions

DRUG

imiquimod 5% cream

1 packet (250 mg cream) 3 times per week for 4 weeks

Sponsors & Collaborators

  • Rigel Dermatology

    lead OTHER

Principal Investigators

  • Darrell S Rigel, MD · Rigel Dermatology

  • James Q Del Rosso, DO · Private Practice

  • James Spencer · Spencer Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00774787 on ClinicalTrials.gov